| Similar Articles |
|---|
 |
The Motley Fool
July 25, 2011
Morgan Housel |
4 Companies You Can Buy Today These are cheap by the numbers.   |
The Motley Fool
October 25, 2010
Morgan Housel |
5 Companies You Can Buy Today These are cheap by the numbers: Johnson & Johnson... Kraft Foods... IBM... Costco... Wal-Mart... |
The Motley Fool
January 26, 2010
Morgan Housel |
6 Companies You Can Buy Today By this metric, unlevered cash flow to total enterprise value, these companies look cheap: UnitedHealth...Dell... Raytheon... Pfizer... Gap... International Paper... |
The Motley Fool
August 19, 2010
Brian Orelli |
Buffett Is Buying J&J. Should You? It depends on your time horizon. |
The Motley Fool
August 28, 2010
Todd Wenning |
Dividend Report Card: Johnson & Johnson Does this health-care titan's dividend pass the test? |
The Motley Fool
August 23, 2010
Jordan DiPietro |
How Safe Are Eli Lilly's Dividends? Check out how Eli Lilly stacks up |
The Motley Fool
October 28, 2010
Matt Koppenheffer |
Blue Chips Are Crazy Cheap Blue chip stocks are where investors should be focusing, and there's good reason why. |
The Motley Fool
August 24, 2010
Matt Koppenheffer |
How Much Is Johnson & Johnson Worth? Is Johnson & Johnson's stock on sale? |
The Motley Fool
February 23, 2010
Morgan Housel |
6 More Companies You Can Buy Today These stocks look cheap by this metric. The metric is simple, but seldom used: enterprise value over unlevered free cash flow. |
The Motley Fool
July 12, 2011
Todd Wenning |
What Does Johnson & Johnson Do With Its Free Cash? Johnson & Johnson appears to be making fair use of its free cash flow, and its well-covered dividend may be attractive to income-focused investors. |
The Motley Fool
June 25, 2010
Morgan Housel |
5 Companies You Can Buy Today It's time to buy. Here are five places to start. |
The Motley Fool
November 14, 2011 |
A Brief History of Intel's Returns The good news is that at about 12 times earnings, Intel's situation couldn't be in a more different spot today than it was 10 years ago. |
The Motley Fool
January 10, 2007
John Reeves |
Is Your Stock a Dog? A dividend yield can be a very misleading ratio, and when it comes to identifying stable companies that deliver regular and growing cash flows, you must look deeper than just a single metric. |
The Motley Fool
August 24, 2011
Andrew Tonner |
Does Bristol-Myers Squibb Look Like a Winning Investment? Bristol-Myers, Pfizer, and J&J all look tempting, trading in the mid-teens relative to their earnings. |
The Motley Fool
September 24, 2010
Anand Chokkavelu |
10 Core Stocks for Your Portfolio: Johnson & Johnson The health care behemoth makes the list |
The Motley Fool
August 11, 2010
David Meier |
Does Bill Miller Think Johnson & Johnson Is Attractive? Johnson & Johnson fits Miller's criteria perfectly. It pays a 3.6% dividend that has been growing 11.1%, on average, for the past five years. |
The Motley Fool
August 29, 2008
Richards et al. |
Fool Blog: Stocks We'd Recommend to Our Grandmas In lieu of this crazy market, analysts suggest stocks they would recommend for their own grandmothers? |
The Motley Fool
September 15, 2011
Rich Smith |
Intel Is Smarter Than a Fifth-Grader Every time Intel borrows a buck to buy back shares, it saves itself a net penny. |
The Motley Fool
March 24, 2011
Anand Chokkavelu |
Rising Star Buy: Johnson & Johnson It's time to buy shares of Johnson & Johnson, the "health-care mutual fund." |
The Motley Fool
September 17, 2010
Morgan Housel |
5 Companies That Doubled Earnings While Their Stocks Went Nowhere When being "paid for performance" loses its mind. |
The Motley Fool
September 11, 2010
Anand Chokkavelu |
How Much of a Bargain Is Johnson & Johnson Stock Right Now? Let's take a look to see how cheap shares of Johnson & Johnson are trading, how consistent its performance has been, and what kind of growth profile it has -- both on an absolute and a relative basis. |
The Motley Fool
August 10, 2010
Jim Mueller |
3 Beaten-Down Dividend Payers A look at three companies that might deserve a spot in your portfolio. |
The Motley Fool
January 28, 2011
Anand Chokkavelu |
10 Core Stocks: A Johnson & Johnson Update The steady reliability of J&J stock will comfort the core of your portfolio when the market gets a boo-boo. |
The Motley Fool
January 13, 2012
Morgan Housel |
A New Boom in the Auto Industry? Mesirow Financial chief economist Diane Swonk elaborated on the auto industry's possible revival. |
The Motley Fool
December 18, 2008
Selena Maranjian |
Best Stock for 2009: Johnson & Johnson Johnson & Johnson is a stock that should let you sleep well at night in 2009. |
The Motley Fool
January 18, 2011
Russ Krull |
Keep It or Sweep It: Johnson & Johnson? Should the company be held or sold? |
The Motley Fool
June 11, 2010
Morgan Housel |
5 Dividend Monsters to Buy After the Crash The good news is that the recent crash has turned some traditional dividend stocks into veritable cash cows. Here are five: AT&T... Verizon... Altria... Southern Company... Eli Lilly... |
The Motley Fool
July 22, 2011
Matt Koppenheffer |
Could Eli Lilly's Stock Double Your Money? With concerns swirling around the big pharma companies, could it be time to buy Eli Lilly? |
The Motley Fool
June 30, 2011
Todd Wenning |
10 Stocks That Pay You Back Don't forget to include buybacks. |
The Motley Fool
August 17, 2010
Ilan Moscovitz |
Intel: Dividend Dynamo or Disaster? Just how safe is this dividend? There seems to be quite a bit of room for a rise in dividends, particularly if Intel jump-starts earnings growth. |
The Motley Fool
November 18, 2005
Stephen D. Simpson |
Diving Into the Dow: The Fourth Five The authors banter about the relative merits and investment opportunities of some the biggest companies in America: Honeywell International... Intel... IBM... Johnson & Johnson... JPMorgan Chase... |
The Motley Fool
March 31, 2011
Todd Wenning |
Dividend Sector Review: Pharmaceuticals These pharmaceutical stocks generate an adequate amount of free cash flow to fund their well above-average dividend yields. |
The Motley Fool
January 3, 2011
Rex Moore |
Highest-Yielding Pharma Stocks (You Might Actually Want to Buy) How to combine high yield with low risk. |
The Motley Fool
November 26, 2010
Roger Friedman |
3 Unbelievable Bargains to Buy Right Now Here are three great stocks to watch, and three great companies you can't afford to miss. |
The Motley Fool
August 24, 2010
Jordan DiPietro |
Intel's Dividends May Not Last Forever If Intel can illustrate that it's grown dividends over the past five years, then there's a good chance that it will continue to put shareholders first in the future. |
The Motley Fool
August 16, 2010
Todd Wenning |
Dividend Report Card: Intel Does Intel's dividend pass the test? |
The Motley Fool
November 22, 2006
Brian Lawler |
Dueling Fools: Johnson & Johnson Bear J&J's dividend does provide investors with some degree of income, but a CD does, too -- without a health-care stock's risks. |
The Motley Fool
February 8, 2011
Brian Stoffel |
This Stock Has It All This versatile technology stock is sitting right under your nose. Look no further than the technology stock I'm recommending today: Intel |
The Motley Fool
August 3, 2010
Morgan Housel |
5 Companies You Can Buy Today It's time to buy. Here are five ideas to get you going. |
The Motley Fool
February 25, 2011
Rex Moore |
Rising Star Buys: 2 Health Care Winners Abbott Laboratories and Johnson & Johnson are being added to the Motley Fool multivitamin portfolio. |
The Motley Fool
July 21, 2011
Todd Wenning |
What Does IBM Do With Its Free Cash? Let's find out whether it's a good steward of your capital. |
The Motley Fool
August 8, 2006
Selena Maranjian |
4 Blue-Chip Bargains Have you noticed? Some big and beautiful companies are selling at attractive prices. Wal-Mart... Home Depot... PepsiCo... Johnson & Johnson... |
The Motley Fool
November 29, 2011
John Grgurich |
3 Strong Yields From the Market's Biggest and Brightest Companies Earn sustainable dividends from companies you can count on to stick around: Intel... Microsoft... Johnson & Johnson... |
BusinessWeek
October 21, 2010 |
William Priest: Following the Cash Flow The founder of Epoch Investment Partners hunts for companies deploying cash in shareholder-friendly ways. |
The Motley Fool
May 31, 2007
Brian Lawler |
Dueling Fools: Eli Lilly Bear Well-managed companies don't always make for good investments. This pharmaceutical powerhouse is a good example. |
The Motley Fool
June 15, 2006
Selena Maranjian |
My Dividends Are Bigger Than Yours Your yield may be 2% when mine is a whopping 13%. Here's the secret. |
The Motley Fool
March 23, 2011
Todd Wenning |
Dividend Report Card: Pfizer Investors considering Pfizer as a dividend play should decide if the combination of 4% current yield and low- to mid-single-digit dividend growth potential is a better deal than other pharmaceutical shares are offering. |
The Motley Fool
May 3, 2007
Joe Magyer |
The Weekly Dividend Could your portfolio use a Band-Aid? PepsiCo... Arch Coal... Dow Chemical... Johnson & Johnson... etc. |
The Motley Fool
November 30, 2010
Jeremy Phillips |
What You Must Know About Intel Learn the most important metrics when evaluating a CEO. |
The Motley Fool
June 14, 2011
Alex Pape |
4 Simple Options Trades Anyone Can Make Today Don't let options intimidate or confuse you. |
